Structure Therapeutics Inc - American Depositary Shares - fluxo de caixa (NASDAQ:GPCR) | MetaTrader

Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas

Cash from operating activities -79.49 M-116.64 M-222.2 M -222.2 M Cash from investing activities -268.34 M-358.91 M89.8 M 89.8 M Cash from financing activities 451.53 M515.26 M762.52 M 762.52 M Free cash flow -81.66 M-117.93 M-225.81 M -225.81 M

Notícias

Structure Therapeutics nomeia Matthew Lang como COO e conselheiro geral

Does NVO Face Rising Competitive Pressure on LLY's Foundayo Approval?

Structure Therapeutics: The Oral Obesity Inflection, Best-In-Class Efficacy

Desenvolvedores de medicamentos para perda de peso se alinham para explorar o lucrativo mercado à medida que concorrência se acirra

Structure Therapeutics: A High-Risk, High-Reward Bet On The Next GLP-1 Blockbuster (GPCR)

Wolfe Research inicia cobertura de Structure Therapeutics com classificação Peerperform

NVO vs. GPCR: Which Obesity Stock is the Better Buy Right Now?

Eli Lilly's Experimental Drug Retatrutide Delivers Strong Weight Loss In Late-Stage Trial

Why Did Eli Lilly Stock Slide 6% Despite Strong GLP-1 Momentum?

BMO eleva preço-alvo da Structure Therapeutics após dados de medicamento para obesidade

BMO raises Structure Therapeutics stock price target on obesity drug data

Structure Therapeutics' GLP-1 Agonist Could Be A Potential Acquisition Target (GPCR)